An internal analysis conducted by Johnson & Johnson in 2011 not long after it recalled a troubled hip implant estimated that the all-metal device would fail within five years in nearly 40 percent of patients who received it, according to court records in a trial expected to begin Friday in California Superior Court in Los Angeles, the New York Times reports.